In patients who progress to pneumonia - chills, chest pain, nausea, vomiting and diarrhea may occur
Dry, nonproductive cough occurs 3 - 5 days after onset of initial nonspecific symptoms
Later, cough may produce mucopurulent sputum
Patients usually seek medical attention on days 5-7, when cough may become paroxysmal and nocturnal
Cough may persist several weeks following resolution of constitutional symptoms
Extrapulmonary manifestations of M. pneumoniae infections
Immunologically-mediated syndromes
Skin rashes
Erythema nodosum or erythema multiforme
Anemia
Thrombocytopenia
Guillain-Barré syndrome
Syndromes caused by the spread of organism
Bullous hemorrhagic otitis
Arthritis
Acute respiratory distress syndrome (ARDS)
Myocarditis
Encephalitis/meningitis
Diagnosis
Clinical signs:
Crackles or wheezes on auscultation of the chest
Chest radiograph findings - patchy, unilateral infiltrates or diffuse, bilateral interstitial process
Since pneumonia caused by M. pneumoniae may be indistinguishable from viral causes and other atypical pathogens such as Chlamydia pneumoniae, Bordetella pertussis, Legionella and others, laboratory confirmation is appropriate for patient management
Paired sera obtained with a time interval of 1 to 3 weeks are highly recommended in adults to confirm reinfection by M. pneumoniae, which is demonstrated by a significant change in IgG antibodies.
Guidelines
Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Infectious Diseases Society of America - Medical Specialty Society. 2000 Feb (revised 2003 Dec 1). 29 pages. NGC:003360
(Link to NGC)
General References
Beersma MF, Dirven K, van Dam AP, Templeton KE, Claas EC, Goossens H.Evaluation of 12 commercial tests and the complement fixation test for Mycoplasma pneumoniae-specific immunoglobulin G (IgG) and IgM antibodies, with PCR used as the "gold standard".J Clin Microbiol. 2005;43(5):2277-2285. (Link to PubMed)
Guleria R, Nisar N, Chawla TC, Biswas NR.Mycoplasma pneumoniae and central nervous system complications: a review.J Lab Clin Med. 2005;146(2):55-63. (Link to PubMed)
Waites KB, Talkington DF.Mycoplasma pneumoniae and its role as a human pathogen.Clin Microbiol Rev. 2004;17(4):697-728, table. (Link to PubMed)
Waites KB.New concepts of Mycoplasma pneumoniae infections in children.Pediatr Pulmonol. 2003;36(4):267-278. (Link to PubMed)
Reviewed by
Hillyard, David R., M.D. Medical Director, Molecular Infectious Diseases at ARUP Laboratories; Associate Professor, Pathology, University of Utah
Litwin, Christine, M.D. Medical Director, Immunology at ARUP Laboratories; Professor, Clinical Pathology, University of Utah
Petti, Cathy A., M.D. Medical Director, Infectious Diseases at ARUP Laboratories; Assistant Professor, Pathology and Medicine, University of Utah
Comprehensive Review: September 2007
Last Update: September 2007